These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3099625

  • 21. A rapid one-step immunoradiometric assay for factor VIII-procoagulant antigen utilizing monoclonal antibodies.
    Stel HV, Veerman EC, Huisman JG, Janssen MC, van Mourik JA.
    Thromb Haemost; 1983 Dec 30; 50(4):860-3. PubMed ID: 6420924
    [Abstract] [Full Text] [Related]

  • 22. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
    Warren DL, Morrissey JH, Neuenschwander PF.
    Biochemistry; 1999 May 18; 38(20):6529-36. PubMed ID: 10350471
    [Abstract] [Full Text] [Related]

  • 23. Immunoaffinity purification of factor VIII complex.
    Hornsey VS, Griffin BD, Pepper DS, Micklem LR, Prowse CV.
    Thromb Haemost; 1987 Feb 03; 57(1):102-5. PubMed ID: 3109055
    [Abstract] [Full Text] [Related]

  • 24. Factor VIII S373L: mutation at P1' site confers thrombin cleavage resistance, causing mild haemophilia A.
    Johnson DJ, Pemberton S, Acquila M, Mori PG, Tuddenham EG, O'Brien DP.
    Thromb Haemost; 1994 Apr 03; 71(4):428-33. PubMed ID: 8052958
    [Abstract] [Full Text] [Related]

  • 25. The subunit structure of normal and hemophilic factor VIII.
    Shapiro GA, Andersen JC, Pizzo SV, McKee PA.
    J Clin Invest; 1973 Sep 03; 52(9):2198-210. PubMed ID: 4199414
    [Abstract] [Full Text] [Related]

  • 26. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
    Shima M, Scandella D, Yoshioka A, Nakai H, Tanaka I, Kamisue S, Terada S, Fukui H.
    Thromb Haemost; 1993 Mar 01; 69(3):240-6. PubMed ID: 7682339
    [Abstract] [Full Text] [Related]

  • 27. [Acquired hemophilia A due to factor VIIIC inhibitor: detection of circulating immune complexes containing factor VIIIC but not factor VIIIR].
    Pfyffer M, Kistler HJ, von Felten A.
    Schweiz Med Wochenschr; 1983 Oct 08; 113(40):1456-9. PubMed ID: 6417777
    [Abstract] [Full Text] [Related]

  • 28. Acquired haemophilia: functional study of antibodies to Factor VIII.
    Allain JP, Gaillandre A, Frommel D.
    Thromb Haemost; 1981 Jun 30; 45(3):285-9. PubMed ID: 6792741
    [Abstract] [Full Text] [Related]

  • 29. Structure and function of factor VIII procoagulant protein.
    Fulcher CA, Zimmerman TS.
    Prog Clin Biol Res; 1984 Jun 30; 150():57-71. PubMed ID: 6431442
    [No Abstract] [Full Text] [Related]

  • 30. Studies on human factor VIII and its antibodies using radiolabelling and affinity chromatography.
    Kavanagh ML, Wood CN, Davidson JF.
    Thromb Haemost; 1981 Jun 30; 45(3):267-71. PubMed ID: 6792739
    [Abstract] [Full Text] [Related]

  • 31. Dissociation of the Factor-VIII complex during clotting: role of thrombin and phospholipids.
    Muntean W, Rothwangl HJ.
    Eur J Clin Invest; 1984 Dec 30; 14(6):462-8. PubMed ID: 6441724
    [Abstract] [Full Text] [Related]

  • 32. Thrombin activation of factor VIII. II. A comparison of purified factor VIII and the low molecular weight factor VIII procoagulant.
    Rick ME, Hoyer LW.
    Br J Haematol; 1978 Jan 30; 38(1):107-19. PubMed ID: 638056
    [Abstract] [Full Text] [Related]

  • 33. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R, De Filippis V.
    Biochem J; 2003 Jul 15; 373(Pt 2):593-601. PubMed ID: 12689334
    [Abstract] [Full Text] [Related]

  • 34. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
    Donath MJ, Lenting PJ, Van Mourik JA, Mertens K.
    Eur J Biochem; 1996 Sep 01; 240(2):365-72. PubMed ID: 8841400
    [Abstract] [Full Text] [Related]

  • 35. [Dissociation of human factor VIII and recombination of the fragments VIII-C and VIII-AG].
    Tran TH, Bounameaux H, Marbet GA, Duckert F.
    Schweiz Med Wochenschr; 1979 Jul 14; 109(28):1029-34. PubMed ID: 462170
    [Abstract] [Full Text] [Related]

  • 36. Thrombin activation of factor VIII: the effect of inhibitors.
    Rick ME, Hoyer LW.
    Br J Haematol; 1977 Aug 14; 36(4):585-97. PubMed ID: 889721
    [Abstract] [Full Text] [Related]

  • 37. The influence of thrombin on the clotting activity of factor VIII. A study with insolubilized thrombin.
    Vukovich T, Koller E, Doleschel W.
    Thromb Haemost; 1978 Jun 30; 39(3):600-6. PubMed ID: 705688
    [Abstract] [Full Text] [Related]

  • 38. Thrombin proteolysis of purified factor viii procoagulant protein: correlation of activation with generation of a specific polypeptide.
    Fulcher CA, Roberts JR, Zimmerman TS.
    Blood; 1983 Apr 30; 61(4):807-11. PubMed ID: 6403080
    [Abstract] [Full Text] [Related]

  • 39. Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody.
    Fulcher CA, Zimmerman TS.
    Proc Natl Acad Sci U S A; 1982 Mar 30; 79(5):1648-52. PubMed ID: 6803246
    [Abstract] [Full Text] [Related]

  • 40. Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V.
    Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS.
    Blood; 1984 Feb 30; 63(2):486-9. PubMed ID: 6419799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.